Jonathan E Freeman is Director of Phio Pharmaceuticals Corp.. Currently has a direct ownership of 1,000 shares of PHIO, which is worth approximately $1,830. The most recent transaction as insider was on Sep 11, 2024, when has been sold 1,000 shares (Common Stock, $0.0001 par value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1K
0% 3M change
68.72% 12M change
Total Value Held $1,830

Jonathan E Freeman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 11 2024
BUY
Grant, award, or other acquisition
-
1,000 Added 50.0%
1,000 Common Stock, $0.0001 ...
Feb 17 2023
BUY
Grant, award, or other acquisition
-
1,500 Added 31.94%
3,197 Common Stock, $0.0001 ...
Feb 15 2022
BUY
Grant, award, or other acquisition
-
10,000 Added 32.93%
20,364 Common Stock, $0.0001 ...
Mar 01 2021
BUY
Grant, award, or other acquisition
-
10,000 Added 49.11%
10,364 Common Stock, $0.0001 ...
JEF

Jonathan E Freeman

Director
Marlborough, MA

Track Institutional and Insider Activities on PHIO

Follow Phio Pharmaceuticals Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHIO shares.

Notify only if

Insider Trading

Get notified when an Phio Pharmaceuticals Corp. insider buys or sells PHIO shares.

Notify only if

News

Receive news related to Phio Pharmaceuticals Corp.

Track Activities on PHIO